A STUDY ON PHARMACODYNAMIC DRUG INTERACTION OF :在药效学相互作用的研究.docVIP

A STUDY ON PHARMACODYNAMIC DRUG INTERACTION OF :在药效学相互作用的研究.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
A STUDY ON PHARMACODYNAMIC DRUG INTERACTION OF :在药效学相互作用的研究.doc

A STUDY ON PHARMACODYNAMIC DRUG INTERACTION OF ESOMEPRAZOLE AND ANTIDIABETIC DRUGSS. Protocol of Dissertation Submitted By Mr. PRASHANT DNYANDEO PHADATARE. To RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES BANGALORE, KARNATAKA. Under the guidance of Mr. CHANDRASHEKHAR V.M. Assist. Professor (2008-2009) Department of Pharmacology, HANAGAL SHRI KUMARESHWAR COLLEGE OF PHARMACY, BAGALKOT- 587101, KARNATAKA RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES BANGALORE, KARNATAKA ANNEXURE II PROFORMA FOR REGISTRATION OF SUBJECTS FOR DISSERATATION 1. Name of the Candidate and Address PRASHANT DNYANDEO PHADATARE. DEPARTMENT OF PHARMACOLOGY, H.S.K.COLLEGE OF PHARMACY, B.V.V.S. CAMPUS, BAGALKOT-587101. KARNATAKA. 2. Name of the Institution H.S.K.COLLEGE OF PHARMACY, B.V.V.S.CAMPUS, BAGALKOT-587101. KARNATAKA. 3. Course of Study and Subject MASTER OF PHARMACY IN PHARMACOLOGY 4. Date of admission to Course 17-O7-2008 5. Title of the topic: “A STUDY ON PHARMACODYNAMIC DRUG INTERACTION OF ESOMEPRAZOLE AND ANTIDIABETIC DRUGS” 6. Brief resume of the intended work 6.1 Need for the study: Drug interaction can be defined as the modification of the effect of one drug by the prior or concomitant administration of another drug. The more drugs a patient takes the greater the likelihood that an adverse reaction will occur. One hospital study found that the rate was 7 % in those taking 6 to 10 drugs, but 40% in those taking 16 to 20 drugs which represents a disproportionate increase1.According to one report , the drug interaction may be fourth to sixth leading cause of death in united sates2. Recent studies have demonstrated that may patient receive multiple drug therapy with recognize potential. When patient has subjected various therapeutics regimen increases, the greater is the risk of occurrence of drug interaction3.This may lead to enhanced or diminished effect and may be useful or harmful. The responsible position lies between these two extremes because

文档评论(0)

cai + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档